Edwin H. Kolodny
Affiliations: | Neurology | New York University, New York, NY, United States |
Google:
"Edwin Kolodny"Bio:
MD
NEW YORK NUNIVERSITY MEDICAL CENTER
NEUROLOGY DEPT
550 1ST AVE
NEW YORK, NY 100166402
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mistry PK, Batista JL, Andersson HC, et al. (2017) Transformation in Pre-treatment Manifestations of Gaucher Disease Type 1 during Two Decades of Alglucerase/Imiglucerase Enzyme Replacement Therapy in the International Collaborative Gaucher Group (ICGG) Registry. American Journal of Hematology |
El-Beshlawy A, Tylki-Szymanska A, Vellodi A, et al. (2016) Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism |
Desnick RJ, Barton NW, Furbish S, et al. (2016) Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues. Molecular Genetics and Metabolism |
Tatlisumak T, Putaala J, Innilä M, et al. (2016) Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population. Journal of Neurology. 263: 257-262 |
Kolodny E, Fellgiebel A, Hilz MJ, et al. (2015) Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke; a Journal of Cerebral Circulation. 46: 302-13 |
Wessels ME, Holmes JP, Jeffrey M, et al. (2014) GM2 gangliosidosis in British Jacob sheep. Journal of Comparative Pathology. 150: 253-7 |
Böttcher T, Rolfs A, Tanislav C, et al. (2013) Fabry disease - underestimated in the differential diagnosis of multiple sclerosis? Plos One. 8: e71894 |
Pierson TM, Torres PA, Zeng BJ, et al. (2013) Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase. Molecular Genetics and Metabolism. 108: 65-9 |
Leone P, Shera D, McPhee SW, et al. (2012) Long-term follow-up after gene therapy for canavan disease. Science Translational Medicine. 4: 165ra163 |
Flint D, Li R, Webster LS, et al. (2012) Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Human Mutation. 33: 1141-8 |